ORTINLAB — Ortin Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹152.06m
- IN₹208.88m
- IN₹60.20m
- 29
- 27
- 33
- 15
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.56 | ||
| Price to Tang. Book | 1.56 | ||
| Price to Free Cashflow | 10.86 | ||
| Price to Sales | 4.44 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.57% | ||
| Return on Equity | -40.25% | ||
| Operating Margin | -105.77% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 1,677.62 | 1,973.91 | 81.67 | 82.31 | 60.2 | n/a | n/a | -40.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +232.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ortin Laboratories Limited is engaged in manufacturing and trading of pharmaceuticals, drugs, and intermediates. It manufactures a range of pharmaceutical formulations of tablets, capsules, syrups, and dry powders. The Company's products include Acefinac, ACEFINAC-CZ, ACEFINAC-P, ACEFINAC-SP, ACTAZID, ACTY-P, ALERFEX-120, ALERFEX-180, ALERGID, ALERGID- L, AMLOBID, CARBAMOL, CARISNIL, CALDY-C AZITIN-500, DOCEF-200, GLYCITROL, GLYCITROL-M, LORACT, MEBOL, NEUROCOB, FERUP, IRFER Z, MINVITA-B, NILCID, ORICILLIN-DX, PEG POWDER, PEG-D POWDER, ALKASIT, COF-XL, DECODIL, ENCENIL and OROMOX DRY SYRUP. Its formulations include Anti Diabetics, Anti Allergics, Anti Anginal and Cardiovascular, Analgesics and Antipyretics, and Anti Biotics-Quinolones. Its active pharmaceutical ingredient (API) intermediates include Anti retro viral, Grignard, Diborane, Ciprofloxacin and Tramadol. It is also manufacturing for different importers to market their products in Russia, Ukraine, Kajakistan and South America.
Directors
- Sanka Kumar CFO (53)
- Bhupathiraju Raju CFO (69)
- Nitesh Sharma CCO
- Sanka Krishna Murthy MDR
- Sanka Venkateswarlu EDR
- Datla Raju EDR
- Gaddam Ramana NED (52)
- Pottur Sujatha IND
- J. R. K. Panduranga Rao NID
- Murali Rayaprolu NID
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 27th, 1986
- Public Since
- November 15th, 1996
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 8,131,400
- Address
- Flat No: 502, Palem Towers, Barkatpura, HYDERABAD, 500044
- Web
- http://www.ortinlabsindia.com/
- Phone
- +91 4027567266
- Auditors
- Sathuluri & Co
Upcoming Events for ORTINLAB
Q1 2025 Ortin Laboratories Ltd Earnings Release
Ortin Laboratories Ltd Annual Shareholders Meeting
Q2 2025 Ortin Laboratories Ltd Earnings Release
Similar to ORTINLAB
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Ortin Laboratories share price?
As of Today at 19:16 UTC, shares in Ortin Laboratories are trading at IN₹18.70. This share price information is delayed by 15 minutes.
How has the Ortin Laboratories share price performed this year?
Shares in Ortin Laboratories last closed at IN₹18.70 and the price had moved by -3.86% over the past 365 days. In terms of relative price strength the Ortin Laboratories share price has underperformed the S&P BSE 100 Index by -24.98% over the past year.
What are the analyst and broker recommendations for Ortin Laboratories?
There is no consensus recommendation for this security.
What is the Ortin Laboratories dividend yield?
Ortin Laboratories does not currently pay a dividend.
Does Ortin Laboratories pay a dividend?
Ortin Laboratories does not currently pay a dividend.
When does Ortin Laboratories next pay dividends?
Ortin Laboratories does not currently pay a dividend.
How do I buy Ortin Laboratories shares?
To buy shares in Ortin Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ortin Laboratories?
As of the previous close price of IN₹18.70, shares in Ortin Laboratories had a market capitalisation of IN₹152.06m.
Where are Ortin Laboratories shares listed?
Here are the trading details for Ortin Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ORTINLAB
What kind of share is Ortin Laboratories?
Based on an overall assessment of its quality, value and momentum Ortin Laboratories is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ortin Laboratories share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Ortin Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ortin Laboratories. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -17.2%.
As of the last closing price of IN₹18.70, shares in Ortin Laboratories were trading -6.48% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ortin Laboratories PE Ratio?
The Ortin Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹18.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ortin Laboratories?
Ortin Laboratories' management team is headed by:
- Sanka Kumar - CFO
- Bhupathiraju Raju - CFO
- Nitesh Sharma - CCO
- Sanka Krishna Murthy - MDR
- Sanka Venkateswarlu - EDR
- Datla Raju - EDR
- Gaddam Ramana - NED
- Pottur Sujatha - IND
- J. R. K. Panduranga Rao - NID
- Murali Rayaprolu - NID